May 25, 2026 | 10:31
A 36-year-old Pakistani patient has shown encouraging early recovery following personalised CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, after standard treatments for aggressive recurrent blood cancer were exhausted.